查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390857

2023-2028 年药物器材组合产品市场报告（按产品、应用、最终用户和地区）

Drug Device Combination Products Market Report by Product, Application, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球药物器材组合产品市场规模达到1,436亿美元。展望未来， IMARC Group预计到2028年市场规模将达到2,304亿美元，2022-2028年复合年增长率（CAGR）为8.20%。

药物器械组合产品包括医疗器械和药物成分，有助于将药物输送到患者体内的特定位置。它们包括包装有输送装置的疫苗瓶、带有手术单和麻醉拭子的手术托盘，以及预装药物输送系统，如注射器、胰岛素注射笔和定量吸入器。常见的药物器械组合产品包括单株抗体与治疗药物的组合、带有类固醇涂层尖端的起搏导线、带有抗菌涂层的导管以及含有绷带和纱布的急救包等。

药物器材组合产品市场趋势：

慢性病的日益普及以及对疾病治疗新方法的需求不断增加是推动全球药物器材组合产品采用的关键因素。这些产品可以帮助患有癌症、心臟病、多发性硬化症、脑性麻痹、脊髓损伤、贫血、肝炎、类风湿性关节炎、糖尿病和其他严重疾病的患者。此外，这些产品还具有一些优点，例如副作用最小、药物给药受控、患者依从性提高以及标靶药物传输。再加上人们对智慧和精准药物传输系统的日益青睐，这些系统可以减少治疗效果所需的药物量，从而促进了市场的成长。除此之外，市场参与者正在将技术融入药物器材组合产品中，以用于追踪和监控目的。他们还推出了使用复杂的活性成分、配方、递送途径和剂型製成的复杂产品，例如胜肽、脂质体和透皮製剂。此外，他们还专注于开发具有高黏度、配方和新型生物製剂的下一代产品。因此，预计对这些产品的需求将会上升，以便为患者提供更好地坚持治疗的治疗和解决方案。

本报告回答的关键问题：

  • 迄今为止，全球药物器械组合产品市场表现如何，未来几年将如何表现？
  • COVID-19 对全球药物器材组合产品市场有何影响？
  • 主要区域市场有哪些？
  • 基于产品的市场区隔是什么？
  • 基于应用程式的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球药物器材组合产品市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球药物器材组合产品市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 药物洗脱支架
    • 市场走向
    • 市场预测
  • 透皮贴剂
    • 市场走向
    • 市场预测
  • 点滴帮浦
    • 市场走向
    • 市场预测
  • 药物洗脱球囊
    • 市场走向
    • 市场预测
  • 吸入器
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 心血管
    • 市场走向
    • 市场预测
  • 糖尿病
    • 市场走向
    • 市场预测
  • 癌症治疗
    • 市场走向
    • 市场预测
  • 呼吸疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Baxter International Inc.
    • Bayer AG
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Medtronic plc
    • Novartis AG
    • Smith & Nephew plc
    • Stryker Corporation
    • Terumo Corporation
Product Code: SR112023A4751

Abstract

The global drug device combination products market size reached US$ 143.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 230.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.20% during 2022-2028.

Drug device combination products comprise medical devices and pharmaceutical ingredients, which assist in delivering the drug to a specific location in the patient's body. They include vaccine vials packaged with a delivery device, surgical trays with drapes and anesthetic swabs, and prefilled drug delivery systems like syringes, insulin injector pens, and metered dose inhalers. Some of the commonly available drug device combination products are monoclonal antibody combined with a therapeutic drug, pacing lead with steroid-coated tip, and catheter with an antimicrobial coating, and first-aid kits containing bandages and gauze are some.

Drug Device Combination Products Market Trends:

The growing prevalence of chronic diseases and the escalating demand for new approaches in treating diseases are among the key factors driving the adoption of drug device combination products across the globe. These products help patients suffering from cancer, heart disease, multiple sclerosis, cerebral palsy, spinal cord injuries, anemia, hepatitis, rheumatoid arthritis, diabetes, and other serious conditions. Moreover, these products offer advantages, such as minimal side effects, controlled drug administration, improved patient compliance, and targeted drug delivery. This, coupled with increasing preferences for smart and precision drug delivery systems that reduce the amount of drug required for therapeutic efficacy, is contributing to the market growth. Apart from this, market players are incorporating technologies into drug device combination products for tracking and monitoring purposes. They are also introducing sophisticated products made using complex active ingredients, formulations, routes of delivery, and dosage forms, such as peptides, liposomes, and transdermal. Additionally, they are focusing on developing next-generation products with high viscosity, formulations, and new classes of biologics. As a result, the demand for these products is anticipated to rise for providing patients treatments and solutions that can better adhere to their therapy.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug device combination products market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Drug Eluting Stents

Transdermal Patches

Infusion Pumps

Drug Eluting Balloon

Inhalers

Others

Breakup by Application:

Cardiovascular

Diabetes

Cancer Treatment

Respiratory Diseases

Others

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Boston Scientific Corporation, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Novartis AG, Smith & Nephew plc, Stryker Corporation and Terumo Corporation.

Key Questions Answered in This Report:

  • How has the global drug device combination products market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug device combination products market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug device combination products market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Device Combination Products Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Drug Eluting Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transdermal Patches
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Infusion Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Drug Eluting Balloon
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Inhalers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Cardiovascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diabetes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cancer Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Respiratory Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boston Scientific Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GlaxoSmithKline plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novartis AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smith & Nephew plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Device Combination Products Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Device Combination Products Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Drug Device Combination Products Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Drug Device Combination Products Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Drug Device Combination Products Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Drug Device Combination Products Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Drug Device Combination Products Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Drug Device Combination Products (Drug Eluting Stents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Drug Device Combination Products (Drug Eluting Stents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Drug Device Combination Products (Transdermal Patches) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Drug Device Combination Products (Transdermal Patches) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Drug Device Combination Products (Infusion Pumps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Drug Device Combination Products (Infusion Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Drug Device Combination Products (Drug Eluting Balloon) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Drug Device Combination Products (Drug Eluting Balloon) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Drug Device Combination Products (Inhalers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Drug Device Combination Products (Inhalers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Drug Device Combination Products (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Drug Device Combination Products (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Drug Device Combination Products (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Drug Device Combination Products (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Drug Device Combination Products (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Drug Device Combination Products (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Drug Device Combination Products (Cancer Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Drug Device Combination Products (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Drug Device Combination Products (Respiratory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Drug Device Combination Products (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Drug Device Combination Products (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Drug Device Combination Products (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Drug Device Combination Products (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Drug Device Combination Products (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Drug Device Combination Products (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Drug Device Combination Products (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Drug Device Combination Products (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Drug Device Combination Products (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Drug Device Combination Products Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Drug Device Combination Products Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Drug Device Combination Products Industry: SWOT Analysis
  • Figure 86: Global: Drug Device Combination Products Industry: Value Chain Analysis
  • Figure 87: Global: Drug Device Combination Products Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Device Combination Products Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Drug Device Combination Products Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Drug Device Combination Products Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Drug Device Combination Products Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Drug Device Combination Products Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Drug Device Combination Products Market: Competitive Structure
  • Table 7: Global: Drug Device Combination Products Market: Key Players